{"id":342744,"date":"2025-08-20T19:56:01","date_gmt":"2025-08-20T19:56:01","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-ibio\/"},"modified":"2025-08-20T19:56:01","modified_gmt":"2025-08-20T19:56:01","slug":"how-to-buy-ibio","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/","title":{"rendered":"iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; iBio, Inc. (IBIO) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334117,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-342744","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r - iBio, Inc. (IBIO) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r - iBio, Inc. (IBIO) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Bu umut vadeden biyoteknoloji hissesinde ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 vermek ve iBio, Inc. (IBIO) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 \u00f6\u011frenin. G\u00fcncel fiyat, trendler ve uzman analizlerini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Bu umut vadeden biyoteknoloji hissesinde ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 vermek ve iBio, Inc. (IBIO) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 \u00f6\u011frenin. G\u00fcncel fiyat, trendler ve uzman analizlerini ke\u015ffedin."},"intro":"Biyoteknolojinin \u00f6nc\u00fc d\u00fcnyas\u0131na yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? iBio, Inc. (IBIO), devrim niteli\u011findeki antikor terapileriyle yapay zek\u00e2 destekli t\u0131bb\u0131n gelece\u011fini temsil ediyor. Bu k\u00fc\u00e7\u00fck sermayeli de\u011ferli hisse, erken a\u015fama biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131n risklerini ve \u00f6d\u00fcllerini anlayan ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in patlay\u0131c\u0131 b\u00fcy\u00fcme potansiyeli sunabilir.","intro_source":{"label":"Intro","type":"text","formatted_value":"Biyoteknolojinin \u00f6nc\u00fc d\u00fcnyas\u0131na yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? iBio, Inc. (IBIO), devrim niteli\u011findeki antikor terapileriyle yapay zek\u00e2 destekli t\u0131bb\u0131n gelece\u011fini temsil ediyor. Bu k\u00fc\u00e7\u00fck sermayeli de\u011ferli hisse, erken a\u015fama biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131n risklerini ve \u00f6d\u00fcllerini anlayan ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in patlay\u0131c\u0131 b\u00fcy\u00fcme potansiyeli sunabilir."},"body_html":"<h2>\ud83d\udcc8 iBio Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla iBio, Inc. (IBIO) NASDAQ borsas\u0131nda <strong>0,7329 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>19 Eyl\u00fcl 2025<\/strong> kesinlikle kritik bir tarih\u2014iBio'nun bir sonraki kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn. Tarihsel olarak, bu anlar bu volatil biyoteknoloji hissesinde b\u00fcy\u00fck fiyat dalgalanmalar\u0131na yol a\u00e7\u0131yor.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 IBIO Hissesini Nas\u0131l Hareket Ettirir<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>8 May\u0131s 2025<\/td><td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>0,68 $<\/td><td>%8,2 Art\u0131\u015f (1 hafta)<\/td><\/tr> <tr><td>12 \u015eubat 2025<\/td><td>Pipeline G\u00fcncellemesi<\/td><td>0,72 $<\/td><td>%15,3 Art\u0131\u015f (GLP-1 sinerji haberi)<\/td><\/tr> <tr><td>5 Kas\u0131m 2024<\/td><td>Lisans Anla\u015fmas\u0131<\/td><td>0,65 $<\/td><td>%22,1 Art\u0131\u015f (Activin E antikoru)<\/td><\/tr> <tr><td>9 A\u011fustos 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>0,78 $<\/td><td>%18,4 D\u00fc\u015f\u00fc\u015f (hedeflerin ka\u00e7\u0131r\u0131lmas\u0131)<\/td><\/tr> <tr><td>15 May\u0131s 2024<\/td><td>Finansman Turu<\/td><td>0,82 $<\/td><td>%12,2 D\u00fc\u015f\u00fc\u015f (seyrelme endi\u015feleri)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: \u015eubat 2025 GLP-1 sinerji duyurusu gibi olumlu klinik veriler fiyatlar\u0131 %15-20 oran\u0131nda yukar\u0131 f\u0131rlatabilir. Olumsuz kazan\u00e7lar veya seyrelme haberleri keskin d\u00fc\u015f\u00fc\u015flere neden olur, ancak hisse genellikle pipeline ilerlemesiyle toparlan\u0131r.<\/p>  [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2> <p>iBio hisseleri bu d\u00f6nemde toplamda <strong>%42<\/strong> oran\u0131nda dalgalanan \u00e7\u0131lg\u0131n bir ini\u015f \u00e7\u0131k\u0131\u015f ya\u015fad\u0131:<\/p> <ul> <li><strong>\u015eubat<\/strong>: 1,26 $ (GLP-1 sinerji duyurusu sonras\u0131 zirve)<\/li> <li><strong>Mart<\/strong>: 0,94 $ (ilk y\u00fckseli\u015f sonras\u0131 kar realizasyonu)<\/li> <li><strong>May\u0131s<\/strong>: 0,68 $ (3. \u00e7eyrek kazan\u00e7lar\u0131 sonras\u0131 konsolidasyon)<\/li> <li><strong>Temmuz<\/strong>: 0,61 $ (yaz aylar\u0131nda biyoteknoloji sekt\u00f6r zay\u0131fl\u0131\u011f\u0131)<\/li> <li><strong>A\u011fustos<\/strong>: 0,73 $ (teklif haberiyle mevcut toparlanma)<\/li> <\/ul> <p><strong>Neden bu volatilite?<\/strong><\/p> <ul> <li>Klinik deneme g\u00fcncellemelerine a\u015f\u0131r\u0131 duyarl\u0131l\u0131k<\/li> <li>Finansman turlar\u0131na y\u00fcksek ba\u011f\u0131ml\u0131l\u0131k<\/li> <li>K\u00fc\u00e7\u00fck piyasa de\u011feri (14,89M $) abart\u0131l\u0131 hareketlere yol a\u00e7\u0131yor<\/li> <li>Biyoteknoloji sekt\u00f6r\u00fc duyarl\u0131l\u0131k dalgalanmalar\u0131<\/li> <\/ul>  <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030<\/h2> <ul> <li><strong>2025 (Y\u0131l Sonu)<\/strong>: 5,00-5,50 $ (klinik veri tetikleyicileri + teklif tamamlanmas\u0131) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li> <li><strong>2026<\/strong>: 6,50-7,50 $ (Faz 1 deneme ba\u015flatma ivmesi)<\/li> <li><strong>2028<\/strong>: 11,00-13,00 $ (orta a\u015fama klinik ilerleme)<\/li> <li><strong>2030<\/strong>: 19,30 $ (potansiyel ticarile\u015ftirme senaryolar\u0131)<\/li> <\/ul> <p><strong>Karar<\/strong>: Bu, spek\u00fclatif tahsis i\u00e7in m\u00fckemmel olan <strong>y\u00fcksek riskli, y\u00fcksek getirili<\/strong> bir f\u0131rsatt\u0131r. Mevcut fiyat ile analist hedefleri aras\u0131ndaki b\u00fcy\u00fck fark ya muazzam bir y\u00fckseli\u015f ya da tam bir ba\u015far\u0131s\u0131zl\u0131k anlam\u0131na gelir.<\/p>  <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Klinik ba\u015far\u0131s\u0131zl\u0131k riski<\/strong>: Klinik \u00f6ncesi ila\u00e7lar\u0131n %90'\u0131 piyasaya ula\u015famaz<\/li> <li><strong>Seyrelme tehlikesi<\/strong>: Son 50M $ tutar\u0131ndaki halka arz (<a href=\"https:\/\/ir.ibioinc.com\/news-events\/press-releases\/detail\/244\/ibio-announces-pricing-of-50-million-public-offering\">iBio Bas\u0131n B\u00fclteni<\/a>) hisse say\u0131s\u0131n\u0131 art\u0131r\u0131yor<\/li> <li><strong>Nakit yak\u0131m\u0131<\/strong>: 375K $ gelirle -20,99M $ net zarar<\/li> <li><strong>Reg\u00fclasyon engelleri<\/strong>: FDA onaylar\u0131 asla garanti de\u011fildir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>GLP-1 sinerjisi<\/strong>: Kas kayb\u0131 olmadan %26'dan fazla ya\u011f azalt\u0131m\u0131 (<a href=\"https:\/\/ir.ibioinc.com\/news-events\/press-releases\">May\u0131s 2025 Verileri<\/a>)<\/li> <li><strong>\u0130nsana benzemeyen primat \u00e7al\u0131\u015fmas\u0131<\/strong>: IBIO-610 umut vaat ediyor (<a href=\"https:\/\/ir.ibioinc.com\">Haziran 2025 G\u00fcncellemesi<\/a>)<\/li> <li><strong>Analist iyimserli\u011fi<\/strong>: Ortalama 5,50 $ hedef %650 y\u00fckseli\u015f potansiyeli sunuyor<\/li> <li><strong>Obezite pazar\u0131 patlamas\u0131<\/strong>: Y\u0131ll\u0131k %14 b\u00fcy\u00fcyen 100 milyar $+ pazar<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>\u00c7ok k\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2'sinden fazlas\u0131n\u0131 bu spek\u00fclasyona ay\u0131rmay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Zamanlama hatalar\u0131ndan ka\u00e7\u0131nmak i\u00e7in haftal\u0131k k\u00fc\u00e7\u00fck al\u0131mlar yap\u0131n<\/li> <li><strong>Sert durdurma noktalar\u0131 belirleyin<\/strong>: Bu volatilite i\u00e7in %25-30 maksimum zarar tolerans\u0131<\/li> <li><strong>19 Eyl\u00fcl'\u00fc izleyin<\/strong>: Kazan\u00e7lar bir sonraki b\u00fcy\u00fck kataliz\u00f6r\u00fc sa\u011flayabilir<\/li> <\/ol> <p>Esprili bir yorum: \"IBIO ticareti yapmak, dahi bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014inan\u0131lmaz potansiyel ama dramatik ruh hali de\u011fi\u015fimleri ve pahal\u0131 al\u0131\u015fkanl\u0131klara meyilli!\"<\/p>  <h2>\u2705 iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ hisseleri ve kesirli paylar sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>K\u00fc\u00e7\u00fck miktarlarla ba\u015flay\u0131n\u2014mikro yat\u0131r\u0131m i\u00e7in 50 $ bile yeterlidir<\/td><\/tr> <tr><td>3<\/td><td>\"IBIO\" aramas\u0131 yap\u0131n<\/td><td>Sadece \"iBio\" de\u011fil, tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Limit emirleri volatilite zirvelerinde fazla \u00f6deme yapmay\u0131 \u00f6nler<\/td><\/tr> <tr><td>5<\/td><td>Sat\u0131n al\u0131m\u0131 onaylay\u0131n<\/td><td>T\u00fcm \u00fccretleri g\u00f6zden ge\u00e7irin\u2014toplam i\u015flem maliyeti %1'in alt\u0131nda olmal\u0131<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Pocket Option Yeni Biyoteknoloji Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Neden Uygun?<\/h2> <p>Pocket Option, biyoteknoloji hisselerine inan\u0131lmaz esneklikle eri\u015fim sa\u011flar:<\/p> <ul> <li><strong>Minimum depozito: 5 $<\/strong> \u2014 riskli biyoteknoloji oyunlar\u0131n\u0131 taahh\u00fcts\u00fcz test etmek i\u00e7in m\u00fckemmel<\/li> <li><strong>An\u0131nda do\u011frulama<\/strong> \u2014 herhangi bir kimlik y\u00fckleyin ve dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>Kesirli hisseler<\/strong> \u2014 pahal\u0131 hisselerin k\u00fc\u00e7\u00fck par\u00e7alar\u0131n\u0131 sat\u0131n al\u0131n<\/li> <li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> \u2014 kripto, e-c\u00fczdanlar, banka transferleri mevcut<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, IBIO gibi y\u00fcksek volatiliteye sahip hisselerde k\u00fc\u00e7\u00fck miktarlarla potansiyel olarak b\u00fcy\u00fck getiriler i\u00e7in denemeler yapmak isteyenler i\u00e7in idealdir.<\/p>  <h2>\ud83c\udf0d 2025'te iBio: Yapay Zek\u00e2 T\u0131bb\u0131n\u0131n Y\u00fckselen Y\u0131ld\u0131z\u0131<\/h2> <p>iBio, devrim niteli\u011findeki platformlar\u0131yla yapay zek\u00e2 destekli antikor ke\u015ffi alan\u0131nda liderdir. \u015eirket, bitki bazl\u0131 \u00fcretim k\u00f6kenlerinden tamamen keskin hesaplamal\u0131 biyoloji g\u00fcc\u00fcne d\u00f6n\u00fc\u015fm\u00fc\u015ft\u00fcr. Obezite tedavilerinin \u00f6tesinde, hassas t\u0131bb\u0131 yeniden tan\u0131mlayabilecek kanser imm\u00fcnoterapileri \u00f6nc\u00fcl\u00fc\u011f\u00fcn\u00fc yap\u0131yorlar.<\/p> <p><strong>2025 e\u011flenceli bilgi<\/strong>: iBio'nun yapay zek\u00e2 platformu, Activin E antikorunu tasarlamak i\u00e7in 2 milyondan fazla protein yap\u0131s\u0131n\u0131 analiz etti\u2014bu, Kongre K\u00fct\u00fcphanesi'ndeki her kitab\u0131 20 kez okuyup m\u00fckemmel bir c\u00fcmleyi bulmak gibi!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 iBio Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla iBio, Inc. (IBIO) NASDAQ borsas\u0131nda <strong>0,7329 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>19 Eyl\u00fcl 2025<\/strong> kesinlikle kritik bir tarih\u2014iBio&#8217;nun bir sonraki kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn. Tarihsel olarak, bu anlar bu volatil biyoteknoloji hissesinde b\u00fcy\u00fck fiyat dalgalanmalar\u0131na yol a\u00e7\u0131yor.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 IBIO Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>8 May\u0131s 2025<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>0,68 $<\/td>\n<td>%8,2 Art\u0131\u015f (1 hafta)<\/td>\n<\/tr>\n<tr>\n<td>12 \u015eubat 2025<\/td>\n<td>Pipeline G\u00fcncellemesi<\/td>\n<td>0,72 $<\/td>\n<td>%15,3 Art\u0131\u015f (GLP-1 sinerji haberi)<\/td>\n<\/tr>\n<tr>\n<td>5 Kas\u0131m 2024<\/td>\n<td>Lisans Anla\u015fmas\u0131<\/td>\n<td>0,65 $<\/td>\n<td>%22,1 Art\u0131\u015f (Activin E antikoru)<\/td>\n<\/tr>\n<tr>\n<td>9 A\u011fustos 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>0,78 $<\/td>\n<td>%18,4 D\u00fc\u015f\u00fc\u015f (hedeflerin ka\u00e7\u0131r\u0131lmas\u0131)<\/td>\n<\/tr>\n<tr>\n<td>15 May\u0131s 2024<\/td>\n<td>Finansman Turu<\/td>\n<td>0,82 $<\/td>\n<td>%12,2 D\u00fc\u015f\u00fc\u015f (seyrelme endi\u015feleri)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: \u015eubat 2025 GLP-1 sinerji duyurusu gibi olumlu klinik veriler fiyatlar\u0131 %15-20 oran\u0131nda yukar\u0131 f\u0131rlatabilir. Olumsuz kazan\u00e7lar veya seyrelme haberleri keskin d\u00fc\u015f\u00fc\u015flere neden olur, ancak hisse genellikle pipeline ilerlemesiyle toparlan\u0131r.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2>\n<p>iBio hisseleri bu d\u00f6nemde toplamda <strong>%42<\/strong> oran\u0131nda dalgalanan \u00e7\u0131lg\u0131n bir ini\u015f \u00e7\u0131k\u0131\u015f ya\u015fad\u0131:<\/p>\n<ul>\n<li><strong>\u015eubat<\/strong>: 1,26 $ (GLP-1 sinerji duyurusu sonras\u0131 zirve)<\/li>\n<li><strong>Mart<\/strong>: 0,94 $ (ilk y\u00fckseli\u015f sonras\u0131 kar realizasyonu)<\/li>\n<li><strong>May\u0131s<\/strong>: 0,68 $ (3. \u00e7eyrek kazan\u00e7lar\u0131 sonras\u0131 konsolidasyon)<\/li>\n<li><strong>Temmuz<\/strong>: 0,61 $ (yaz aylar\u0131nda biyoteknoloji sekt\u00f6r zay\u0131fl\u0131\u011f\u0131)<\/li>\n<li><strong>A\u011fustos<\/strong>: 0,73 $ (teklif haberiyle mevcut toparlanma)<\/li>\n<\/ul>\n<p><strong>Neden bu volatilite?<\/strong><\/p>\n<ul>\n<li>Klinik deneme g\u00fcncellemelerine a\u015f\u0131r\u0131 duyarl\u0131l\u0131k<\/li>\n<li>Finansman turlar\u0131na y\u00fcksek ba\u011f\u0131ml\u0131l\u0131k<\/li>\n<li>K\u00fc\u00e7\u00fck piyasa de\u011feri (14,89M $) abart\u0131l\u0131 hareketlere yol a\u00e7\u0131yor<\/li>\n<li>Biyoteknoloji sekt\u00f6r\u00fc duyarl\u0131l\u0131k dalgalanmalar\u0131<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030<\/h2>\n<ul>\n<li><strong>2025 (Y\u0131l Sonu)<\/strong>: 5,00-5,50 $ (klinik veri tetikleyicileri + teklif tamamlanmas\u0131) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li>\n<li><strong>2026<\/strong>: 6,50-7,50 $ (Faz 1 deneme ba\u015flatma ivmesi)<\/li>\n<li><strong>2028<\/strong>: 11,00-13,00 $ (orta a\u015fama klinik ilerleme)<\/li>\n<li><strong>2030<\/strong>: 19,30 $ (potansiyel ticarile\u015ftirme senaryolar\u0131)<\/li>\n<\/ul>\n<p><strong>Karar<\/strong>: Bu, spek\u00fclatif tahsis i\u00e7in m\u00fckemmel olan <strong>y\u00fcksek riskli, y\u00fcksek getirili<\/strong> bir f\u0131rsatt\u0131r. Mevcut fiyat ile analist hedefleri aras\u0131ndaki b\u00fcy\u00fck fark ya muazzam bir y\u00fckseli\u015f ya da tam bir ba\u015far\u0131s\u0131zl\u0131k anlam\u0131na gelir.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Klinik ba\u015far\u0131s\u0131zl\u0131k riski<\/strong>: Klinik \u00f6ncesi ila\u00e7lar\u0131n %90&#8217;\u0131 piyasaya ula\u015famaz<\/li>\n<li><strong>Seyrelme tehlikesi<\/strong>: Son 50M $ tutar\u0131ndaki halka arz (<a href=\"https:\/\/ir.ibioinc.com\/news-events\/press-releases\/detail\/244\/ibio-announces-pricing-of-50-million-public-offering\">iBio Bas\u0131n B\u00fclteni<\/a>) hisse say\u0131s\u0131n\u0131 art\u0131r\u0131yor<\/li>\n<li><strong>Nakit yak\u0131m\u0131<\/strong>: 375K $ gelirle -20,99M $ net zarar<\/li>\n<li><strong>Reg\u00fclasyon engelleri<\/strong>: FDA onaylar\u0131 asla garanti de\u011fildir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>GLP-1 sinerjisi<\/strong>: Kas kayb\u0131 olmadan %26&#8217;dan fazla ya\u011f azalt\u0131m\u0131 (<a href=\"https:\/\/ir.ibioinc.com\/news-events\/press-releases\">May\u0131s 2025 Verileri<\/a>)<\/li>\n<li><strong>\u0130nsana benzemeyen primat \u00e7al\u0131\u015fmas\u0131<\/strong>: IBIO-610 umut vaat ediyor (<a href=\"https:\/\/ir.ibioinc.com\">Haziran 2025 G\u00fcncellemesi<\/a>)<\/li>\n<li><strong>Analist iyimserli\u011fi<\/strong>: Ortalama 5,50 $ hedef %650 y\u00fckseli\u015f potansiyeli sunuyor<\/li>\n<li><strong>Obezite pazar\u0131 patlamas\u0131<\/strong>: Y\u0131ll\u0131k %14 b\u00fcy\u00fcyen 100 milyar $+ pazar<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>\u00c7ok k\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2&#8217;sinden fazlas\u0131n\u0131 bu spek\u00fclasyona ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Zamanlama hatalar\u0131ndan ka\u00e7\u0131nmak i\u00e7in haftal\u0131k k\u00fc\u00e7\u00fck al\u0131mlar yap\u0131n<\/li>\n<li><strong>Sert durdurma noktalar\u0131 belirleyin<\/strong>: Bu volatilite i\u00e7in %25-30 maksimum zarar tolerans\u0131<\/li>\n<li><strong>19 Eyl\u00fcl&#8217;\u00fc izleyin<\/strong>: Kazan\u00e7lar bir sonraki b\u00fcy\u00fck kataliz\u00f6r\u00fc sa\u011flayabilir<\/li>\n<\/ol>\n<p>Esprili bir yorum: &#8220;IBIO ticareti yapmak, dahi bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014inan\u0131lmaz potansiyel ama dramatik ruh hali de\u011fi\u015fimleri ve pahal\u0131 al\u0131\u015fkanl\u0131klara meyilli!&#8221;<\/p>\n<h2>\u2705 iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ hisseleri ve kesirli paylar sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>K\u00fc\u00e7\u00fck miktarlarla ba\u015flay\u0131n\u2014mikro yat\u0131r\u0131m i\u00e7in 50 $ bile yeterlidir<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;IBIO&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Sadece &#8220;iBio&#8221; de\u011fil, tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Limit emirleri volatilite zirvelerinde fazla \u00f6deme yapmay\u0131 \u00f6nler<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sat\u0131n al\u0131m\u0131 onaylay\u0131n<\/td>\n<td>T\u00fcm \u00fccretleri g\u00f6zden ge\u00e7irin\u2014toplam i\u015flem maliyeti %1&#8217;in alt\u0131nda olmal\u0131<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Biyoteknoloji Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Neden Uygun?<\/h2>\n<p>Pocket Option, biyoteknoloji hisselerine inan\u0131lmaz esneklikle eri\u015fim sa\u011flar:<\/p>\n<ul>\n<li><strong>Minimum depozito: 5 $<\/strong> \u2014 riskli biyoteknoloji oyunlar\u0131n\u0131 taahh\u00fcts\u00fcz test etmek i\u00e7in m\u00fckemmel<\/li>\n<li><strong>An\u0131nda do\u011frulama<\/strong> \u2014 herhangi bir kimlik y\u00fckleyin ve dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>Kesirli hisseler<\/strong> \u2014 pahal\u0131 hisselerin k\u00fc\u00e7\u00fck par\u00e7alar\u0131n\u0131 sat\u0131n al\u0131n<\/li>\n<li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> \u2014 kripto, e-c\u00fczdanlar, banka transferleri mevcut<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, IBIO gibi y\u00fcksek volatiliteye sahip hisselerde k\u00fc\u00e7\u00fck miktarlarla potansiyel olarak b\u00fcy\u00fck getiriler i\u00e7in denemeler yapmak isteyenler i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te iBio: Yapay Zek\u00e2 T\u0131bb\u0131n\u0131n Y\u00fckselen Y\u0131ld\u0131z\u0131<\/h2>\n<p>iBio, devrim niteli\u011findeki platformlar\u0131yla yapay zek\u00e2 destekli antikor ke\u015ffi alan\u0131nda liderdir. \u015eirket, bitki bazl\u0131 \u00fcretim k\u00f6kenlerinden tamamen keskin hesaplamal\u0131 biyoloji g\u00fcc\u00fcne d\u00f6n\u00fc\u015fm\u00fc\u015ft\u00fcr. Obezite tedavilerinin \u00f6tesinde, hassas t\u0131bb\u0131 yeniden tan\u0131mlayabilecek kanser imm\u00fcnoterapileri \u00f6nc\u00fcl\u00fc\u011f\u00fcn\u00fc yap\u0131yorlar.<\/p>\n<p><strong>2025 e\u011flenceli bilgi<\/strong>: iBio&#8217;nun yapay zek\u00e2 platformu, Activin E antikorunu tasarlamak i\u00e7in 2 milyondan fazla protein yap\u0131s\u0131n\u0131 analiz etti\u2014bu, Kongre K\u00fct\u00fcphanesi&#8217;ndeki her kitab\u0131 20 kez okuyup m\u00fckemmel bir c\u00fcmleyi bulmak gibi!<\/p>\n"},"faq":[{"question":"iBio hisseleri nereden al\u0131nabilir?","answer":"iBio hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden IBIO sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"iBio hisselerinin riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik ba\u015far\u0131s\u0131zl\u0131k, hisse seyrelmesi, y\u00fcksek nakit yak\u0131m\u0131 ve reg\u00fclasyon engelleri bulunmaktad\u0131r."},{"question":"iBio hisseleri i\u00e7in fiyat tahmini nedir?","answer":"Analistlere g\u00f6re 2025 sonunda fiyat 5,00-5,50 $ aral\u0131\u011f\u0131nda olabilir ve 2030 y\u0131l\u0131nda 19,30 $ seviyesine ula\u015fabilir."},{"question":"Yeni ba\u015flayan biri iBio hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2'sinden fazlas\u0131n\u0131 ay\u0131rmay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, sert durdurma noktalar\u0131 belirleyin ve \u00f6nemli tarihleri takip edin."},{"question":"Pocket Option iBio hisseleri i\u00e7in neden \u00f6neriliyor?","answer":"D\u00fc\u015f\u00fck minimum depozito, an\u0131nda do\u011frulama, kesirli hisse al\u0131m\u0131 ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in esnek ve eri\u015filebilir bir platformdur."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"iBio hisseleri nereden al\u0131nabilir?","answer":"iBio hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden IBIO sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"iBio hisselerinin riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik ba\u015far\u0131s\u0131zl\u0131k, hisse seyrelmesi, y\u00fcksek nakit yak\u0131m\u0131 ve reg\u00fclasyon engelleri bulunmaktad\u0131r."},{"question":"iBio hisseleri i\u00e7in fiyat tahmini nedir?","answer":"Analistlere g\u00f6re 2025 sonunda fiyat 5,00-5,50 $ aral\u0131\u011f\u0131nda olabilir ve 2030 y\u0131l\u0131nda 19,30 $ seviyesine ula\u015fabilir."},{"question":"Yeni ba\u015flayan biri iBio hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2'sinden fazlas\u0131n\u0131 ay\u0131rmay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, sert durdurma noktalar\u0131 belirleyin ve \u00f6nemli tarihleri takip edin."},{"question":"Pocket Option iBio hisseleri i\u00e7in neden \u00f6neriliyor?","answer":"D\u00fc\u015f\u00fck minimum depozito, an\u0131nda do\u011frulama, kesirli hisse al\u0131m\u0131 ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in esnek ve eri\u015filebilir bir platformdur."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r - iBio, Inc. (IBIO) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r - iBio, Inc. (IBIO) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T19:56:01+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; iBio, Inc. (IBIO) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T19:56:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/\",\"name\":\"iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r - iBio, Inc. (IBIO) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"datePublished\":\"2025-08-20T19:56:01+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; iBio, Inc. (IBIO) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r - iBio, Inc. (IBIO) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/","og_locale":"tr_TR","og_type":"article","og_title":"iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r - iBio, Inc. (IBIO) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T19:56:01+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; iBio, Inc. (IBIO) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T19:56:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/","name":"iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r - iBio, Inc. (IBIO) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","datePublished":"2025-08-20T19:56:01+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ibio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"iBio, Inc. (IBIO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; iBio, Inc. (IBIO) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":342748,"slug":"how-to-buy-ibio","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu iBio, Inc. (IBIO) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu iBio, Inc. (IBIO)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ibio\/"},"pt_AA":{"locale":"pt_AA","id":342746,"slug":"how-to-buy-ibio","post_title":"Como comprar a\u00e7\u00f5es da iBio, Inc. (IBIO) - Investimento em a\u00e7\u00f5es da iBio, Inc. (IBIO)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-ibio\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/342744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=342744"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/342744\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334117"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=342744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=342744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=342744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}